Wunala Capital
Growth equitySydney · Growth–Late Stage · 2 people tracked
Investment thesis
Wunala Capital targets late-stage growth capital, bridge and pre-IPO financing, and select listed opportunities across high-growth technology, financial services, data and digital companies. Through its Emerging Opportunities Fund it manages capital for institutional, high-net-worth and family office investors, aiming for a long-term IRR of roughly 20% pre-tax net of fees. The firm emphasizes speed and flexibility in structuring investments, sourcing opportunities in Australia and internationally, and drawing on a team with decades of experience in investments, funds management and leadership of private and public companies. It also helps companies prepare for liquidity events such as IPOs or acquisitions, and offers co-investment opportunities.
Source: firm website, verified Aug 3, 2026.
Team · 2 people
from the firm's websiteFrequently asked questions
- What stage does Wunala Capital invest at?
- Wunala Capital invests at the Growth, Late Stage stages.
- What sectors does Wunala Capital focus on?
- Wunala Capital focuses on Cleantech, Energy, Enterprise Software, Fintech, Sector Agnostic.
- Where is Wunala Capital located?
- Wunala Capital is headquartered in Sydney, AU.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Partech is a global investment firm that supports founders at every stage through dedicated teams and multiple funds across several continents.
General Atlantic is a global investment firm that partners with entrepreneurs and category-leading companies, providing patient capital, operational expertise, and a global platform to support long-term growth.
